AU2019214252B2 - Compounds for the treatment of acute brain injury - Google Patents
Compounds for the treatment of acute brain injury Download PDFInfo
- Publication number
- AU2019214252B2 AU2019214252B2 AU2019214252A AU2019214252A AU2019214252B2 AU 2019214252 B2 AU2019214252 B2 AU 2019214252B2 AU 2019214252 A AU2019214252 A AU 2019214252A AU 2019214252 A AU2019214252 A AU 2019214252A AU 2019214252 B2 AU2019214252 B2 AU 2019214252B2
- Authority
- AU
- Australia
- Prior art keywords
- aryl
- branched
- formula
- linear
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/32—All rings being cycloaliphatic the ring system containing at least eleven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201870067 | 2018-02-02 | ||
| DKPA201870067 | 2018-02-02 | ||
| PCT/DK2019/050041 WO2019149329A1 (en) | 2018-02-02 | 2019-02-01 | Compounds for the treatment of acute brain injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019214252A1 AU2019214252A1 (en) | 2020-08-13 |
| AU2019214252B2 true AU2019214252B2 (en) | 2024-04-04 |
Family
ID=65363024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019214252A Active AU2019214252B2 (en) | 2018-02-02 | 2019-02-01 | Compounds for the treatment of acute brain injury |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12077495B2 (https=) |
| EP (1) | EP3746064B1 (https=) |
| JP (1) | JP7488521B2 (https=) |
| CN (1) | CN111989094A (https=) |
| AU (1) | AU2019214252B2 (https=) |
| CA (1) | CA3089161A1 (https=) |
| ES (1) | ES3035679T3 (https=) |
| WO (1) | WO2019149329A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7709202B2 (ja) * | 2019-06-28 | 2025-07-16 | ユニバーシティ オブ コペンハーゲン | 睡眠障害を伴うcns障害の治療 |
| WO2023170024A1 (en) | 2022-03-11 | 2023-09-14 | University Of Copenhagen | Camk2 modulators and their use in medicine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466715A (en) * | 1991-12-31 | 1995-11-14 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| IT1312362B1 (it) * | 1999-06-29 | 2002-04-15 | Neuroscienze S C A R L | Derivati dell'acido (5,7,8,9-tetraidro-5-idrossi-6h-benzociclo-ept-6-iliden) acetico |
| US20090247770A1 (en) * | 2006-08-09 | 2009-10-01 | Campos Kevin R | Process for making lactam tachykinin receptor antagonists |
| JP6084207B2 (ja) * | 2011-05-13 | 2017-02-22 | ケベンハウンス ウニヴェルジテート(ユニバーシティ オブ コペンハーゲン)Koebenhavns Universitet(University Of Copenhagen) | 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのpsd−95の高親和性二量体阻害剤 |
| WO2013024028A1 (en) | 2011-08-12 | 2013-02-21 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds and compositions for treating proteinopathies |
-
2019
- 2019-02-01 ES ES19704185T patent/ES3035679T3/es active Active
- 2019-02-01 CA CA3089161A patent/CA3089161A1/en active Pending
- 2019-02-01 EP EP19704185.8A patent/EP3746064B1/en active Active
- 2019-02-01 AU AU2019214252A patent/AU2019214252B2/en active Active
- 2019-02-01 WO PCT/DK2019/050041 patent/WO2019149329A1/en not_active Ceased
- 2019-02-01 US US16/965,343 patent/US12077495B2/en active Active
- 2019-02-01 CN CN201980011451.6A patent/CN111989094A/zh active Pending
- 2019-02-01 JP JP2020542088A patent/JP7488521B2/ja active Active
-
2024
- 2024-07-22 US US18/779,719 patent/US20240391865A1/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| Ungnade, H. E. et al., "Methoxy (and Hydroxy) Phenobenzoic Acids, J. Org. Chem., 1951, Vol. 16, pp. 1311-17 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021513522A (ja) | 2021-05-27 |
| EP3746064B1 (en) | 2025-04-16 |
| WO2019149329A1 (en) | 2019-08-08 |
| ES3035679T3 (en) | 2025-09-08 |
| US20240391865A1 (en) | 2024-11-28 |
| US20210122700A1 (en) | 2021-04-29 |
| AU2019214252A1 (en) | 2020-08-13 |
| US12077495B2 (en) | 2024-09-03 |
| CA3089161A1 (en) | 2019-08-08 |
| CN111989094A (zh) | 2020-11-24 |
| JP7488521B2 (ja) | 2024-05-22 |
| EP3746064A1 (en) | 2020-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240391865A1 (en) | Compounds for the treatment of acute brain injury | |
| TWI776886B (zh) | Sestrin-gator2交互作用之調節劑及其用途 | |
| JP7377220B2 (ja) | 代謝障害および非アルコール性脂肪肝疾患の治療のための活性薬剤およびその使用方法 | |
| US9820972B2 (en) | Antiviral compounds highly effective as HCV-NS5A inhibitor | |
| US12060379B2 (en) | Plasmalogen derivatives | |
| KR102537274B1 (ko) | 아마이드 화합물, 이의 약학 조성물 및 이들을 이용하는 방법 | |
| WO2014198195A1 (zh) | 联芳基取代的4-氨基丁酸衍生物及其制备方法和用途 | |
| AU2020358970B2 (en) | Chinone-, hydrochinome- and naphthochinone-analogues of vatiquione for treatment of mitochondrial disorder diseases | |
| EP4029857A1 (en) | Nurr1:rxr activating compounds for simultaneous treatment of symptoms and pathology of parkinson's disease | |
| JP2019523245A (ja) | オーファン核内受容体Nur77のリガンド及びその使用 | |
| WO2018102262A1 (en) | Inhibitors of protein arginine deiminases (pads) and methods of preparation and use thereof | |
| CN102066345B (zh) | *唑烷衍生物作为nmda拮抗剂 | |
| JP2019522650A (ja) | 4−(5−(4,7−ジメチルベンゾフラン−2−イル)−1,2,4−オキサジアゾール−3−イル)安息香酸の結晶形態及びそれらの調製方法 | |
| RU2671194C2 (ru) | Ингибирующие hcv химические соединения, их фармацевтические композиции и применения | |
| WO2019196953A1 (en) | Ntcp inhibitors | |
| CN104557897B (zh) | 法舒地尔‑硫辛酸二联体的合成及其应用 | |
| RU2468000C2 (ru) | Спироциклические циклопропановые аминокислоты - аналоги гамма-аминомасляной кислоты, с ограниченной конформационной подвижностью и фармацевтические композиции на их основе | |
| CN107213153B (zh) | 一种唑来磷酸类化合物在制备治疗癌症药物中的用途 | |
| EP3952873B1 (en) | A class of small-molecule compounds and their prodrugs for intervention with camk2a, and their use in acute brain injuries and central hypersomnias | |
| CN117599063B (zh) | 一种核苷类化合物在制备用于痘病毒相关产品中的用途 | |
| RU2799454C2 (ru) | Терапевтический препарат для лечения нейродегенеративных заболеваний и его применение | |
| JP2020083811A (ja) | 1,5−アンヒドロフルクトース誘導体を含むampk活性化剤 | |
| ES2909707T3 (es) | Mofezolaco y dos derivados para su uso en el tratamiento de la neuroinflamación |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |